Showing results (251-260 of 286) with videos related to

Sort By:
Pageof 29
Nature Communications|September 21, 2018
Differentiation-state plasticity is a targetable resistance mechanism in basal-like breast cancerTyler Risom, Ellen M Langer, Margaret P Chapman, et al.
Nature Communications|March 9, 2017
MAX inactivation is an early event in GIST development that regulates p16 and cell proliferationInga-Marie Schaefer, Yuexiang Wang, Cher-Wei Liang, et al.
Urologic Oncology|September 13, 2015
Neoadjuvant dasatinib for muscle-invasive bladder cancer with tissue analysis of biologic activityNoah M Hahn, Beatrice S Knudsen, Siamak Daneshmand, et al.
Scientific Reports|June 4, 2016
IGF1R as a Key Target in High Risk, Metastatic MedulloblastomaMatthew N Svalina, Ken Kikuchi, Jinu Abraham, et al.
Cancer Cell|December 13, 2006
A collection of breast cancer cell lines for the study of functionally distinct cancer subtypesRichard M Neve, Koei Chin, Jane Fridlyand, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 20, 2015
Phylogenetic analyses of melanoma reveal complex patterns of metastatic disseminationJ Zachary Sanborn, Jongsuk Chung, Elizabeth Purdom, et al.
Cancer Cell|November 6, 2020
Large-Scale Characterization of Drug Responses of Clinically Relevant Proteins in Cancer Cell LinesWei Zhao, Jun Li, Mei-Ju M Chen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 19, 2013
Imatinib for melanomas harboring mutationally activated or amplified KIT arising on mucosal, acral, and chronically sun-damaged skinF Stephen Hodi, Christopher L Corless, Anita Giobbie-Hurder, et al.
Pageof 29